Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalEditorialOtherpeer-review


The review by Gotera that summarized evidences surrounding the available therapeutic agents in patients with coronavirus disease 2019 (COVID-19) is commendable. In addition, the authors listed the possible side effects associated with each of these therapeutic agents, which could serve as a reminder for clinicians who may not be familiar with the safety profile of new or existing but repurposed therapeutic agents for the treatment of COVID-19.
Original languageEnglish
Pages (from-to)690-691
Number of pages2
JournalInternational Brazilian Journal of Urology
Issue number3
Publication statusPublished - May 2021
Externally publishedYes

Cite this